| dc.contributor.author | Shields, B | |
| dc.date.accessioned | 2021-03-18T13:48:13Z | |
| dc.date.issued | 2021-03-18 | |
| dc.description.abstract | Statistical Analysis Plan for TriMaster: Randomised Double-Blind Crossover study
of a DPP4 inhibitor, SGLT2 inhibitor and
thiazolidinedione as third line therapy in patients with
type 2 diabetes who have suboptimal glycaemic
control on dual therapy with metformin and a
sulphonylurea | |
| dc.description.sponsorship | Medical Research Council (MRC) | en_GB |
| dc.identifier.grantnumber | MR/K005707/1 | en_GB |
| dc.identifier.uri | http://hdl.handle.net/10871/125162 | |
| dc.language.iso | en | en_GB |
| dc.publisher | University of Exeter | en_GB |
| dc.rights | © 2021 University of Exeter | en_GB |
| dc.title | Trimaster Statistical Analysis Plan | en_GB |
| dc.type | Report | en_GB |
| dc.date.available | 2021-03-18T13:48:13Z | |
| exeter.confidential | false | en_GB |
| dc.description | This is the final version. | en_GB |
| dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_GB |
| exeter.funder | ::Medical Research Council (MRC) | en_GB |
| exeter.funder | ::Medical Research Council (MRC) | en_GB |
| rioxxterms.version | VoR | en_GB |
| rioxxterms.licenseref.startdate | 2021-03-18 | |
| rioxxterms.type | Technical Report | en_GB |
| refterms.dateFCD | 2021-03-18T13:47:13Z | |
| refterms.versionFCD | VoR | |
| refterms.dateFOA | 2021-03-18T13:48:21Z | |
